Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    -0.50 (-0.14%)
Bid:
351.00
Ask:
356.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

23 Jan 2026 11:36

RNS Number : 1901Q
Caledonia Investments PLC
23 January 2026
 

 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation ("MAR") of the following transactions in its ordinary shares of 0.5p ("Shares") involving one of its directors, Mathew Masters.

 

On 21 January 2026, 136,830 Shares were transferred to Mr Masters under the Caledonia Investments 2020 Performance Share Scheme at nil cost. The Shares were sourced from The Caledonia 2024 Employee Benefit Trust ("EBT"). 

 

On the same date, Mr Masters sold 64,500 Shares back to the EBT to meet the tax liability due. All Shares were sold at 363.75p per Share. He retained 72,330 Shares.

 

Following the above transactions, Mr Masters' total interests in Shares are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

743,780

0.1427%

Non-beneficial

nil

n/a

Performance share scheme awards

851,310

0.1633%

Deferred bonus plan awards

36,520

0.0070%

Shares held under the Caledonia Investments Share Incentive Plan

754

0.0001%

 

Further information required by MAR in relation to these transactions is set out in the appendix below.

 

Enquiries:

Alex Pollard

Senior Assistant Company Secretary

Tel: + 44 20 7802 8080

 

23 January 2026

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Exercise of Caledonia Investments 2020 Performance Share Scheme ("2020 PSS") awards

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£0.00

136,830

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

21 January 2026

f)

Place of the transaction

London - outside a trading venue

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Partial sale of shares to meet tax liability arising from 2020 PSS exercise

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£3.6375

64,500

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

21 January 2026

f)

Place of the transaction

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDBSXDDGLX
Date   Source Headline
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.